Prevention and treatment of chronic respiratory diseases in China
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference21 articles.
1. Healthy China Initiative (2019—2030),2019
2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Zhou;Lancet,2019
3. China Health Statistics Yearbook 2018,2018
4. The new lung cancer staging system;Detterbeck;Chest,2009
5. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage;Newman;Nat Med,2014
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of intestinal microorganisms on immunotherapy of non-small cell lung cancer;Heliyon;2024-05
2. A Flexible and Dual-Channel Sensing System for Long-Term Nasal and Oral Respiration Simultaneously Monitoring;IEEE Sensors Journal;2023-11-15
3. Universal Modeling Method of Electrical Impedance Response During Respiration;Journal of Shanghai Jiaotong University (Science);2023-03-21
4. Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale;ERJ Open Research;2021-07
5. Is the Symptom of Cough in Chronic Obstructive Pulmonary Disease Important?;COPD: Journal of Chronic Obstructive Pulmonary Disease;2020-12-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3